Clinical Trials Logo

Clinical Trial Summary

Researchers plan a 2022 follow-up of medical records data to investigate fracture incidence and survival for 1248 women, born 1902-1931, in a comparative fracture prevention study with 435 participants from an intervention area and 813 participants from two control areas. In 2022 researchers want to assess patient records data in intervention and control areas and compare A) Survival B) Risk factors for osteoporotic fractures (wrist, upper arm, vertebral, pelvic, hip) C) physical activity, exercise and drugs that affect fracture risk.


Clinical Trial Description

Researchers plan a 2022 follow-up of medical records data to investigate fracture incidence and survival for 1248 women, born 1902-1931, in a comparative fracture prevention study with participants from an intervention area (Vislanda, n=435) and control areas (Emmaboda n=395 and Tingsryd (n=418). Fragility fracture prevalence after 40 years of age was 33% in the 1248 participants with mean age 79 years at baseline 2001. Participants with 2-4 risk factors (age ≥80, body weight <60kg, previous fragility fracture or impaired rise-up ability) provided prospective data with FRAMO (FRActure and Mortality) Index as an outcome measure and this index identified 80% of hip, fragility fractures or death within a 2-year follow-up period. Hip fracture incidence 2004-2005 was not significantly lower in the intervention area but the trend of the odds ratio (0.33) was in line with significantly fewer falls and improved recovery in the intervention area. In 2022 researchers want to assess patient records data in intervention and control areas and compare A) Survival B) Risk factors for osteoporotic fractures (wrist, upper arm, vertebral, pelvic, hip) C) physical activity, exercise and drugs that affect fracture risk. Data analysis will be blinded for participation in intervention or control groups and statistical methods include Cox regression and Kaplan-Meier's survival analyzes. Birth cohort differences in outcomes will be analysed by using Lexi's diagrams. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05269979
Study type Interventional
Source Kronoberg County Council
Contact
Status Active, not recruiting
Phase N/A
Start date November 2001
Completion date December 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Active, not recruiting NCT05426356 - Sacral Fracture Fusion/Fixation for Rapid Rehabilitation N/A
Recruiting NCT05489952 - Iron Supplementation for Geriatric Hip Fractures Phase 4
Active, not recruiting NCT04654962 - Use of Anesthetic Block for the Prevention of in Hospital Delirium in Patients of the Orthogeriatric Clinical Care Center of the HUFSFB and HUSJI From 2019 - 2020
Recruiting NCT04787679 - Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
Recruiting NCT04657510 - Femoral frACturEs and COVID-19.
Not yet recruiting NCT06054165 - Impact of a Clinical Pathway for Pelvic Fragility Fractures N/A
Recruiting NCT05712616 - Role of Strontium Ranelate in Proximal Femur Fragility Fractures. Phase 4
Not yet recruiting NCT05837182 - The Role of Augmented Fixation Techniques in Fragility Fracture Pelvis (FFP)
Recruiting NCT05096195 - PRevEnting FracturEs in REnal Disease 1 Phase 4
Completed NCT05721898 - Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability
Recruiting NCT06134908 - PRevention of OsTEoporotiC FracTure 2 Pilot Study N/A
Recruiting NCT04934358 - Motivational Interventions and Physical Exercise in Patients With Fragility Fracture N/A
Not yet recruiting NCT06050668 - Essential Amino Acid Supplementation for Femoral Fragility Fractures N/A
Recruiting NCT05851898 - Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures Phase 4
Recruiting NCT04796350 - RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures N/A